Page 39 - CIBERSAM2016-ENG

Most relevant scientific articles
• Fusar-Poli P., Diaz-Caneja C.M., Patel R., Valmaggia L., Byrne M., Garety P. et al. Services for people at high risk improve outcomes in patients with first episode psychosis. Acta Psychiatrica Scandinavica. 2016;133(1):76-85.
• Arango C, Fraguas D. Should psychiatry deal only with mental disorders without an identified medical aetiology? World psychiatry: official journal of the World Psychiatric Association (WPA). 2016;15(1):22-3.
• Bonnin C.M., Torrent C., Arango C., Amann B.L., Sole B., Gonzalez-Pinto A. et al. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional Outcome. British Journal of Psychiatry. 2016;208(1):87-93.
• Galling B, Roldán A, Nielsen RE, Nielsen J, Gerhard T, Carbon M et al. Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis.JAMA psychiatry. 2016.
• Rapado-Castro M., Dodd S., Bush A.I., Malhi G.S., Skvarc D.R., On Z.X. et al. Cognitive effects of adjunctive N-acetyl cysteine in psychosis. Psychological Medicine. 2016;1-11.
Hightlights
During 2016 the research team of the Department of Psychiatry at Hospital General Universitario Gregorio Marañón (CIBERSAM group 1, G01) has obtained competitive funding for new international projects that add to the previous projects funded by international institutions (EU, NIH) that remain active. In the past few years, the group has become an international reference in the study of first episodes of early onset psychosis. More recently, it has developed a growing interest in primary prevention as manifested by the development of novel research projects focused on the prevention of risk factors in healthy populations. Emphasis should be laid on the incorporation of the group to large international scientific consortia
such as PGC, ENIGMA or ASC, often hand in hand with other CIBERSAM groups. In 2016, G01 has also described potential mechanisms of action to prevent progression after a first episode of psychosis with psychopharmacological and psychosocial interventions. Several members of the group participate in
the development of clinical and therapeutic guidelines through their involvement in expert groups and scientific societies. The quality of the research, teaching, and clinical activity of G01 has been recognized in 2016 with the “AEVAL Management Excellence Award”.
SAM
research groups 39